Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active alpha1-adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3].
Molecular Weight:
423.89
Purity:
99.90
CAS Number:
[63074-08-8]
Formula:
C19H26ClN5O4
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
